BioMelbourne Network
Progressing BioIndustry

• Home
• About Us
• Events
• Grants & Awards
• News & Opinion
• Membership
• Resource Library
• Contact

  24 November 2011. In a major medical breakthrough, an Australian company has developed the world’s first commercial 3D bioprinter, helping organisations working on tissue construction and organ replacement. Start-up company Organovo and Melbourne based Invetech were last night awarded the Engineering Innovation Award, which is sponsored by the Australian Government’s AusIndustry. Congrat... read more…

      22 November 2011. Independent Senator for South Australia Nick Xenophon has called for urgent reforms to the Therapeutic Goods Administration (TGA) and Department of Health and Ageing processes following a Senate Committee report just tabled. The report, from the Senate’s Community Affairs References Committee, inquired into the processes for the approval of medical devices, such as... read more…

22 November 2011.  To access the Australian Senate Committee Report investigating the Regulatory Standards for the approval of medical devices in Australia, click here. read more…

The Medical Technology Association of Australia (MTAA) has welcomed the release of the report from the Australian Senate’s Inquiry into the regulatory standards for the approval of medical devices. The Report includes a range of recommendations not confined to the regulation of medical devices but extending to reimbursement of medical devices, and to ethical conduct in the relationship between ... read more…

The Australian hearing aid company Blamey & Saunders Hearing’s new clinic and offices will be opened this evening at 6 pm at historic 364 Albert Street, East Melbourne, by Michelle Gallaher, CEO of the BioMelbourne Network. The new hearing aid has evolved from sound technologies developed for Graeme Clark’s bionic ear. It empowers users to take control of their own hearing. They can buy online... read more…

23 November 2011HealthLinx Limited (ASX:HTX) has signed legally binding Heads of Agreement with Oryzon Genomics for the distribution of OvPlex™ in Spain, with the option to extend exclusive license rights to Portugal, Andorra, France and Italy. HealthLinx expects to execute the legal distribution agreement by early in the new year, with distribution to begin in Spain in 2012.Oryzon Genomic... read more…

  Monday 21 November 2011. Victorians with a mental illness, carers, researchers and treatment and support providers are being invited to participate in a consultation process as part of the Coalition Government’s $10 million Mental Illness Research Fund. Mental Health Minister Mary Wooldridge said the consultation would help shape the priority research areas to be funded. "The Victoria... read more…

19 November 2011Australian drug delivery technology company Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) has closed its share purchase plan (SPP) heavily oversubscribed.The company has met its target of raising $3 million via the plan. This capital is in addition to the $24.1 million raised via recent placement to institutions and sophisticated investors. Following the scale-back and ro... read more…

Vale Dr Michael Hirshorn OAM Friday 18 November 2011. It is with great regret and sorrow we wish to inform you that, on the morning of Friday 18 November 2011, Mike lost his courageous battle with cancer. He will be dearly missed by his loving family, colleagues and many friends. Mike was Director of Four Hats Capital. He enjoyed a 30 year career of founding, building, managing and investing... read more…

More than 160 guests attended the dinner and Research Australia CEO Elizabeth Foley said “We are pleased to have such a strong showing of our community this year; to us this represents a real coming together in what has been at times a difficult year for the sector. With the threat of funding cuts and the general economic climate presenting many challenges we feel it is all the more important t... read more…